Imagine swallowing a tiny pill that could teach your body's cancer-fighting cells to stay strong for longer. That's exactly what a team of researchers from Korea and the United States has created — and it comes from an unlikely source: the trillions of bacteria living in your gut.
Professor Young Seok Cho from the School of Medicine and Professor James J. Moon from the University of Michigan led the research, published in the journal Nature Nanotechnology. Their team developed the world's first oral nanomedicine made from natural gut bacteria metabolites. The drug could change how doctors treat cancer — and it might one day come as a simple pill you take by mouth, not an injection at a hospital.
The road to this discovery started with a common problem in cancer treatment. Immunotherapy drugs work by waking up the body's own immune system to attack tumors. But these treatments only help about one in three patients. The rest see little to no improvement.
The research team wanted to find out why. They discovered that a substance made by gut bacteria — called 3,4-dihydroxybenzoic acid, or DHB for short — could supercharge cancer-fighting cells called CD8+ T cells. These T cells are the immune system's soldiers, designed to hunt and destroy cancer. But over time, they wear out and stop working properly. DHB keeps them strong and ready for battle, preventing what scientists call "metabolic exhaustion."
There was just one catch: natural DHB breaks down almost instantly in the body, disappearing within minutes of being swallowed. To solve this, the team wrapped the compound in microscopic fatty droplets using a technique called nanoemulsion. They also chemically modified the molecule to make it more stable. The result, nicknamed Prodrug 201, stays in the bloodstream much longer — increasing how much of the drug the body can actually use by 14.3 times.
In animal tests on mice with colorectal cancer, melanoma, and breast cancer, the nanomedicine directed fresh, energized T cells straight to tumors. The tumors shrank dramatically. When researchers combined the treatment with existing immunotherapy drugs, the results were even more striking: the tumors disappeared completely. Even better, the treated animals developed a kind of immune memory, meaning their bodies learned to recognize and fight those cancers again in the future — much like a vaccine.
"This study unveils the molecular secret of how gut microbial metabolites regulate our immune system and successfully translates that knowledge into a convenient oral medication through nanotechnology," said Cho.
The team believes their work could open the door to a new generation of cancer treatments that are both more effective and easier to take. Instead of weeks of hospital visits for IV treatments, patients might one day take a daily pill that works with their body's natural defenses. More research is needed before human trials can begin, but the scientists are hopeful that this gut bacteria discovery could eventually help millions of people around the world survive cancer.